Dynamic hyperinflation in cystic fibrosis

F. Tremblay, J. Morisset, C. Poirier (Montréal, Canada)

Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems
Session: Cystic fibrosis (adults and children): risk factors and clinical problems
Session type: Thematic Poster Session
Number: 1116

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Tremblay, J. Morisset, C. Poirier (Montréal, Canada). Dynamic hyperinflation in cystic fibrosis. Eur Respir J 2012; 40: Suppl. 56, 1116

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Dynamic hyperinflation causes exercise limitation in patients with cystic fibrosis
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016


Exercise in cystic fibrosis
Source: Eur Respir Monogr 2014; 64: 203-218
Year: 2014


Dynamic hyperinflation and daily physical activity in adults with cystic fibrosis
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017


Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis
Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases
Year: 2018

Airway inflammation in cystic fibrosis
Source: Eur Respir Monogr 2014; 64: 14-31
Year: 2014


Cystic fibrosis fibrosis bronchiectasis
Source: Virtual Congress 2020 – Paediatric year in review
Year: 2020

Neomacrolides in cystic fibrosis
Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease
Year: 2012


Peripheral muscle strength and exercise capacity in children with cystic fibrosis and non-cystic fibrosis bronchiectasis
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009

Diagnosing bronchiectasis and cystic fibrosis
Source: International Congress 2018 – ME8 Diagnosing bronchiectasis and cystic fibrosis
Year: 2018


Progressive ventilation inhomogeneity in infants with cystic fibrosis after pulmonary infection
Source: Eur Respir J 2015; 46: 1680-1690
Year: 2015



Revisiting FEV1 in cystic fibrosis
Source: Eur Respir J 2001; 18: Suppl. 33, 127s
Year: 2001

The relationships between hyperinflation during exercise and symptoms in adults with cystic fibrosis
Source: Annual Congress 2012 - Limiting factors in exercise
Year: 2012


Subtypes of pulmonary emphysema on HRCT affect prognosis on combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013


Imaging the lungs in cystic fibrosis
Source: Eur Respir Monogr 2014; 64: 88-103
Year: 2014


The effect of Simeox airway clearance technology on resting hyperinflation in Cystic fibrosis patients
Source: Virtual Congress 2020 – New insights into respiratory physiotherapy
Year: 2020


Airway clearance techniques in cystic fibrosis
Source: Eur Respir J 2006; 27: 1082-1083
Year: 2006


Tidal expiratory flow limitation and chronic dyspnoea in patients with cystic fibrosis
Source: Eur Respir J 2002; 19: 492-498
Year: 2002



A short-term comparison of two methods of sputum expectoration in cystic fibrosis
Source: Eur Respir J 2004; 23: 435-439
Year: 2004



Global impact of bronchiectasis and cystic fibrosis
Source: Breathe 2016; 12: 222-235
Year: 2016